Risk-based classification of medical devices and essential principles MCQs With Answer

Introduction: This quiz collection on risk-based classification of medical devices and essential principles is crafted for M.Pharm students studying Regulatory Aspects of Medical Devices (MRA203T). It focuses on classification frameworks, key rules for implants, active devices, software, and how intended use, duration and invasiveness influence device class. It also examines essential principles such as safety, performance, biocompatibility, clinical evidence, labeling and post-market surveillance. Each multiple-choice question tests applied knowledge required for regulatory submissions, conformity assessment and risk management. Use these MCQs to deepen your understanding of regulatory decision-making, prepare for exams, and link theoretical concepts to practical regulatory pathways and documentation requirements.

Q1. Which two factors form the core basis for risk-based classification of medical devices in most regulatory frameworks?

• Manufacturing process and supplier’s quality system
• Intended purpose and degree of risk (invasiveness, duration, anatomical site)
• Device cost and market size
• Packaging design and distribution channel

Correct Answer: Intended purpose and degree of risk (invasiveness, duration, anatomical site)

Q2. Which regulatory system commonly uses the Class I, II and III risk categories?

• European MDR (Class I, IIa, IIb, III)
• FDA (US) classification system: Class I, II, III
• ISO standards classification: A, B, C, D
• TGA Australia: Class A, B, C, D

Correct Answer: FDA (US) classification system: Class I, II, III

Q3. How is standalone software (Software as a Medical Device, SaMD) typically classified?

• Always Class I regardless of function
• Based solely on software development lifecycle
• Depends on the intended use and the significance of information provided for clinical decision-making
• Classified only by the programming language used

Correct Answer: Depends on the intended use and the significance of information provided for clinical decision-making

Q4. Common classification schemes use duration of contact to assess risk. Which set correctly defines transient, short-term and long-term contact?

• Transient ≤24 h, Short-term ≤30 days, Long-term >30 days
• Transient ≤1 h, Short-term ≤7 days, Long-term >7 days
• Transient ≤12 h, Short-term ≤14 days, Long-term >14 days
• Transient ≤48 h, Short-term ≤60 days, Long-term >60 days

Correct Answer: Transient ≤24 h, Short-term ≤30 days, Long-term >30 days

Q5. Which device attribute commonly causes an upward shift in risk classification?

• Being manufactured in multiple colors
• Having a sterile barrier or being a measuring device
• Being sold at a low price
• Having a complex user manual

Correct Answer: Having a sterile barrier or being a measuring device

Q6. An implantable cardiac valve is usually assigned to which risk class in most risk-based classification systems?

• Class I
• Class IIa
• Class IIb
• Class III

Correct Answer: Class III

Q7. Which of the following is NOT typically listed among the essential principles of safety and performance for medical devices?

• Design and construction consider safety and performance
• Acceptable risk/benefit profile and risk minimization
• Device must be environmentally sustainable regardless of safety
• Information supplied by the manufacturer supports safe use

Correct Answer: Device must be environmentally sustainable regardless of safety

Q8. Which international standard is the primary reference for risk management of medical devices?

• ISO 9001: Quality management systems
• ISO 14971: Risk management for medical devices
• IEC 60601: Electrical safety of medical equipment
• ISO 13485: Quality management for medical devices

Correct Answer: ISO 14971: Risk management for medical devices

Q9. For which class of device is a clinical investigation most often required to demonstrate safety and performance?

• Class I non-sterile, non-measuring
• Class IIa devices with well-established equivalence
• Class III (high risk) devices lacking sufficient clinical evidence
• All devices never require clinical investigations

Correct Answer: Class III (high risk) devices lacking sufficient clinical evidence

Q10. What is the primary purpose of post-market surveillance for medical devices?

• To maximize sales in new markets
• To monitor safety and performance and detect emerging residual risks
• To audit suppliers for cost reduction
• To publish device manuals in multiple languages

Correct Answer: To monitor safety and performance and detect emerging residual risks

Q11. In the European regulatory system under MDR, which devices require involvement of a Notified Body for conformity assessment?

• Only Class I non-sterile, non-measuring
• Class IIa, IIb and III (and Class I sterile/measuring devices require Notified Body)
• All devices irrespective of class
• Notified Body only for software products

Correct Answer: Class IIa, IIb and III (and Class I sterile/measuring devices require Notified Body)

Q12. What does the acronym GSPR refer to in medical device regulation?

• General Safety and Performance Requirements
• Global Supplier Product Registration
• Generic Software Performance Rules
• Governmental Standard for Product Recall

Correct Answer: General Safety and Performance Requirements

Q13. Active implantable medical devices (AIMDs) such as pacemakers are generally placed in which risk class?

• Class I
• Class IIa
• Class IIb
• Class III

Correct Answer: Class III

Q14. A software application that analyzes imaging and provides automated treatment recommendations typically receives what kind of risk classification consideration?

• Lower risk because it only processes images
• Higher risk because it can directly influence immediate treatment decisions
• No classification because software is exempt
• Same as the imaging device used to capture the images

Correct Answer: Higher risk because it can directly influence immediate treatment decisions

Q15. Which statement best reflects an essential principle regarding residual risk and clinical benefit?

• Residual risks may be ignored if manufacturing is consistent
• Residual risks must be minimized and acceptable in relation to the intended clinical benefits
• Residual risks should be communicated only to regulators, not users
• Benefit is irrelevant when assessing residual risk

Correct Answer: Residual risks must be minimized and acceptable in relation to the intended clinical benefits

Q16. What regulatory tool supports traceability and post-market actions by uniquely identifying a medical device?

• CE marking
• UDI (Unique Device Identification)
• ISO 13485 certificate number
• Marketing authorization letter

Correct Answer: UDI (Unique Device Identification)

Q17. Devices with body contact typically require biocompatibility testing. Which standard is commonly referenced for biological evaluation?

• ISO 9001
• ISO 10993 series
• IEC 62304
• ISO 27001

Correct Answer: ISO 10993 series

Q18. What is the regulatory consideration for reprocessing single-use medical devices?

• Single-use devices can be reprocessed without any validation
• Reprocessing is allowed only if validated to ensure safety and performance and compliant with regulations
• All single-use devices are banned from reprocessing worldwide
• Reprocessing is allowed only for Class III devices

Correct Answer: Reprocessing is allowed only if validated to ensure safety and performance and compliant with regulations

Q19. Which conformity assessment route is typically required for high-risk Class III devices in many jurisdictions?

• Self-declaration by the manufacturer without third-party review
• Notified Body or competent authority review including design examination and clinical data assessment
• Notification to local hospital committees only
• Registration with an online portal without documentation

Correct Answer: Notified Body or competent authority review including design examination and clinical data assessment

Q20. Which type of clinical evidence is generally considered the highest level for demonstrating effectiveness and safety?

• Case reports only
• Equivalence claims without supporting data
• Systematic reviews and meta-analyses of randomized controlled trials
• Expert opinion without data

Correct Answer: Systematic reviews and meta-analyses of randomized controlled trials

Download